BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38900223)

  • 1. Misclassification of a frequent variant from PMS2CL pseudogene as a PMS2 loss of function variant in Brazilian patients.
    Segura AVC; da Silva SIO; Santiago KM; Brianese RC; Carraro DM; Torrezan GT
    Fam Cancer; 2024 Jun; ():. PubMed ID: 38900223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reclassification of a frequent African-origin variant from PMS2 to the pseudogene PMS2CL.
    Chong AS; Chong G; Foulkes WD; Saskin A
    Hum Mutat; 2020 Apr; 41(4):749-752. PubMed ID: 31916644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting clinically actionable variants in the 3' exons of PMS2 via a reflex workflow based on equivalent hybrid capture of the gene and its pseudogene.
    Gould GM; Grauman PV; Theilmann MR; Spurka L; Wang IE; Melroy LM; Chin RG; Hite DH; Chu CS; Maguire JR; Hogan GJ; Muzzey D
    BMC Med Genet; 2018 Sep; 19(1):176. PubMed ID: 30268105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PMS2 or PMS2CL? Characterization of variants detected in the 3' of the PMS2 gene.
    Bouras A; Lefol C; Ruano E; Grand-Masson C; Wang Q
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23193. PubMed ID: 37534630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of Lynch syndrome patients.
    van der Klift HM; Tops CM; Bik EC; Boogaard MW; Borgstein AM; Hansson KB; Ausems MG; Gomez Garcia E; Green A; Hes FJ; Izatt L; van Hest LP; Alonso AM; Vriends AH; Wagner A; van Zelst-Stams WA; Vasen HF; Morreau H; Devilee P; Wijnen JT
    Hum Mutat; 2010 May; 31(5):578-87. PubMed ID: 20186688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved multiplex ligation-dependent probe amplification analysis identifies a deleterious PMS2 allele generated by recombination with crossover between PMS2 and PMS2CL.
    Wernstedt A; Valtorta E; Armelao F; Togni R; Girlando S; Baudis M; Heinimann K; Messiaen L; Staehli N; Zschocke J; Marra G; Wimmer K
    Genes Chromosomes Cancer; 2012 Sep; 51(9):819-31. PubMed ID: 22585707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-Source Bioinformatic Pipeline to Improve PMS2 Genetic Testing Using Short-Read NGS Data.
    Munté E; Feliubadaló L; Del Valle J; González S; Ramos-Muntada M; Balmaña J; Ramon Y Cajal T; Tuset N; Llort G; Cadiñanos J; Brunet J; Capellá G; Lázaro C; Pineda M
    J Mol Diagn; 2024 Jun; ():. PubMed ID: 38851388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional PMS2 hybrid alleles containing a pseudogene-specific missense variant trace back to a single ancient intrachromosomal recombination event.
    Ganster C; Wernstedt A; Kehrer-Sawatzki H; Messiaen L; Schmidt K; Rahner N; Heinimann K; Fonatsch C; Zschocke J; Wimmer K
    Hum Mutat; 2010 May; 31(5):552-60. PubMed ID: 20186689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avoidance of pseudogene interference in the detection of 3' deletions in PMS2.
    Vaughn CP; Hart KJ; Samowitz WS; Swensen JJ
    Hum Mutat; 2011 Sep; 32(9):1063-71. PubMed ID: 21618646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variant Detection in 3' Exons of PMS2 Using Exome Sequencing Data.
    Mistry NA; Roellinger SE; Manninen MC; Gandham M; Koganti T; Balan J; Basu S; Blake EJ; Tandale PP; Holdren MA; Hoenig MF; Urban RM; Veith RL; Kendzior MC; Wang C; Gupta S; Shen W
    J Mol Diagn; 2024 Jun; ():. PubMed ID: 38925456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA-based mutation analysis identifies an unusual MSH6 splicing defect and circumvents PMS2 pseudogene interference.
    Etzler J; Peyrl A; Zatkova A; Schildhaus HU; Ficek A; Merkelbach-Bruse S; Kratz CP; Attarbaschi A; Hainfellner JA; Yao S; Messiaen L; Slavc I; Wimmer K
    Hum Mutat; 2008 Feb; 29(2):299-305. PubMed ID: 18030674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes.
    Vaughn CP; Robles J; Swensen JJ; Miller CE; Lyon E; Mao R; Bayrak-Toydemir P; Samowitz WS
    Hum Mutat; 2010 May; 31(5):588-93. PubMed ID: 20205264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of early onset rectal cancer of Lynch syndrome with a novel deleterious PMS2 mutation.
    Nomura S; Fujimoto Y; Yamamoto N; Sato Y; Ashihara Y; Kita M; Yamaguchi J; Ishikawa Y; Ueno M; Arai M
    Jpn J Clin Oncol; 2015 Oct; 45(10):987-92. PubMed ID: 26232782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PMS2 gene mutational analysis: direct cDNA sequencing to circumvent pseudogene interference.
    Wimmer K; Wernstedt A
    Methods Mol Biol; 2014; 1167():289-302. PubMed ID: 24823786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pathogenic Variant Reclassified to the Pseudogene
    Fragoso-Ontiveros V; De la Fuente-Hernandez MA; Gonzalez-Osnaya V; Gamez-Rosales M; Perez-Montiel MD; Isla-Ortiz D; Cantu-De Leon DF; Alvarez-Gomez RM
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-read nanopore sequencing enables accurate confirmation of a recurrent PMS2 insertion-deletion variant located in a region of complex genomic architecture.
    Watson CM; Crinnion LA; Simmonds J; Camm N; Adlard J; Bonthron DT
    Cancer Genet; 2021 Aug; 256-257():122-126. PubMed ID: 34116445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient Detection of Copy Number Mutations in PMS2 Exons with a Close Homolog.
    Herman DS; Smith C; Liu C; Vaughn CP; Palaniappan S; Pritchard CC; Shirts BH
    J Mol Diagn; 2018 Jul; 20(4):512-521. PubMed ID: 29792936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.
    Boumehdi AL; Cherbal F; Khider F; Oukkal M; Mahfouf H; Zebboudj F; Maaoui M
    Ann Hum Genet; 2022 Nov; 86(6):328-352. PubMed ID: 36073783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive gene conversion at the PMS2 DNA mismatch repair locus.
    Hayward BE; De Vos M; Valleley EM; Charlton RS; Taylor GR; Sheridan E; Bonthron DT
    Hum Mutat; 2007 May; 28(5):424-30. PubMed ID: 17253626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frequency of previously undetectable deletions involving 3' Exons of the PMS2 gene.
    Vaughn CP; Baker CL; Samowitz WS; Swensen JJ
    Genes Chromosomes Cancer; 2013 Jan; 52(1):107-12. PubMed ID: 23012243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.